Research Paper Volume 14, Issue 15 pp 6358—6376
Clinical outcomes and potential therapies prediction of subgroups based on a ferroptosis-related long non-coding RNA signature for gastric cancer
Figure 3. Comparison between FRLSG and clinicopathological characteristics in prognosis predicting power. (A, B) Forest plots demonstrating the FRLSG was an independent prognostic factor for GC. (C) Multi-parameter ROC curve showing the AUC of FRLSG (0.762) was higher than other clinicopathological manifestations. (D) Heatmap showing the clinicopathological characteristics and expression of 5 FRLs in the high- and low-FRLSG groups. *P < 0.05, **P < 0.01, and ***P < 0.001.